TRANS GENIC INC.

TRANS GENIC INC. is a company whose strengths include a 40-year history, a proven track record, and technologies developed at GLP-compliant facilities. This section details the features of TRANS GENIC INC.’s nonclinical studies, provides an example of a disease model, and presents case studies. Please use this information as a reference when selecting a contract research company.

Characteristics of TRANS GENIC INC. Non-Clinical Contract Services

Use of Genetically Engineered (TRANS GENIC INC.) Animal Models

Specializes in non-clinical studies using genetically engineered mice and ratsTRANS GENIC INC. is a company whose strengths include a 40-year history, a proven track record, and technologies developed at GLP-compliant facilities. This section details the features of TRANS GENIC INC.’s nonclinical studies, provides an example of a disease model, and presents case studies. Please use this information as a reference when selecting a contract research company.

Providing Diverse Disease Models

TRANS GENIC INC.offers models covering a broad range of disease areas, including the central nervous system, the cardiovascular system, and metabolic diseases, to address varied research needs.

Seamless Support System

A system is in place to support a smooth transition from nonclinical to clinical trial phases, enabling the collection and use of data from early development to advance to subsequent steps efficiently.

Examples of Disease Models Available at TRANS GENIC INC.

It is essential to go through the testing of candidate compounds in animal models that reproduce the target disease before advancing to clinical trials.

However, clinically relevant disease models may not always exist, thus there are demands for animal models with strong clinical correlation.

Below are some examples of disease models offered at Ina Research.

Parkinson’s Disease Model (mouse)

Mice are used as animal models that exhibit key pathological features of Parkinson’s disease. This disease model is expected to support elucidation of Parkinson’s disease mechanisms and the development of new treatment approaches.

Cerebral Infarction (Stroke) Model (rat)

The company maintains a rat model of cerebral infarction to facilitate the development of new treatment methods. This disease model enables evaluation of the effects of therapies and rehabilitation on a range of symptoms caused by cerebral infarction.

TRANS GENIC INC. Non-clinical Case Studies

No case studies are currently listed on the official website.

TRANS GENIC INC. Corporate Information

TRANS GENIC INC. operates a drug discovery support business as well as an investment and consulting business. In drug discovery support, the company provides services spanning from the early stages of discovery through the clinical trial stage, including the creation of genetically engineered animals, nonclinical testing, and antibody production. In its investment and consulting business, the company supports clients through M&A and business restructuring.